CClinicalTrials.gg
CompletedNCT03744364MADUTERUpdated Nov 16, 2018

Low-dose Vaginal Misoprostol Versus Vaginal Dinoprostone Insert for Induction of Labor

A Phase 4 interventional study of Misoprostol 25 mcg and Dinoprostone 10mg in Induced Labor, Cervical Ripening and Obstetric Labor, sponsored by Hospital Miguel Servet. Completed. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-11-16.

Sponsored by Hospital Miguel Servet · Phase 4, Interventional, and Treatment

From the registry’s dates

  • Registered 4 years 5 months after the study started (first participant enrolled Jun 2014, registered Nov 2018).
Phase
Phase 4
Study type
Interventional
Enrollment
198
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

Purpose:

To compare the efficacy and safety of low-dose protocol of vaginal misoprostol and vaginal dinoprostone insert for induction of labor in women with post-term pregnancies.

Methods:

The investigators designed a prospective, randomized, open-labeled, blinded for the end-point evaluators trial including women of at least 41 weeks of gestational age with uncomplicated singleton pregnancies and Bishop score lower than 6. Participants were randomized into dinoprostone or misoprostol groups in a 1:1 ratio. Baseline maternal data and perinatal outcomes were recorded for statistical analysis. Successful vaginal delivery within 24 hours was the primary outcome variable.

02

Conditions studied

  • Induced Labor
  • Cervical Ripening
  • Obstetric Labor
  • Pregnancy

Keywords

  • Dinoprostone
  • Misoprostol
03

In context

Lead sponsor

Hospital Miguel Servet is the lead sponsor of 25 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Singleton uncomplicated pregnancy
  • Nulliparity
  • Live fetus
  • 286 days of gestational age or above
  • Abscence of contraindication for vaginal delivery
  • Bishop score lower than 6

Exclusion criteria

Exclusion Criteria:

  • Multiple pregnancy
  • Multiparity
  • Stillbirth
  • Oligohydramnios
  • Suspected fetal distress
  • Severe asthma
  • Intolerance/allergy to prostaglandins
  • Contraindication for vaginal birth
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
198 participants (actual)

Study arms

  • Active comparator
    Misoprostol

    Group of women allocated to misoprostol induction.

    Drug: Misoprostol 25 mcg

  • Active comparator
    Dinoprostone

    Group of women allocated to dinoprostone induction.

    Drug: Dinoprostone 10mg

Interventions

  • DrugMisoprostol 25 mcg

    To determine efficacy and safety of vaginal 'Misoprostol 25 mcg' every 4 hours with a maximum of 6 doses for induction of labor.

    Also known as: Misoprostol induction

  • DrugDinoprostone 10mg

    To determine efficacy and safety of 'Dinoprostone 10mg' vaginal insert for induction of labor.

    Also known as: Dinoprostone induction

06

What researchers measure

Primary outcomes

  1. Successful vaginal delivery within 24 hours

    Percentage of women that achieve a vaginal delivery within 24 hours since induction process started

    Time frame: 24 hours since induction was started

Secondary outcomes

  1. Successful cervical ripening within 24 hours

    Percentage of women that achieve Bishop score \> 6 within 24 hours since induction process started

    Time frame: 24 hours since induction was started

  2. Interval time from induction to delivery

    Time passed since induction of labor started until delivery

    Time frame: Hours passed between induction of labor until delivery within 72 hours

  3. Need for a second induction

    Percentage of women that require to use a second method for induction of labor after 24 hours of having started induction of labor

    Time frame: Assessed 24 hours since induction of labor was started

  4. Vaginal delivery rate

    Percentage of women that achieve vaginal delivery

    Time frame: Since labor induction had started until delivery had ocurred within 72 hours

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • De Bonrostro Torralba C, Tejero Cabrejas EL, Envid Lazaro BM, Franco Royo MJ, Roca Arquillue M, Campillos Maza JM. Low-dose vaginal misoprostol vs vaginal dinoprostone insert for induction of labor beyond 41st week: A randomized trial. Acta Obstet Gynecol Scand. 2019 Jul;98(7):913-919. doi: 10.1111/aogs.13556. Epub 2019 Feb 24. PubMed 30723912 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 16, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03744364
Lead sponsor
Hospital Miguel Servet
Responsible party
Jose Manuel Campillos Maza (Head of Unit of Maternal-Fetal Medicine, Hospital Miguel Servet) — Principal investigator
First posted
Nov 16, 2018
Start date
Jun 1, 2014
Primary completion
Oct 20, 2017
Completion
Nov 1, 2017
Last update
Nov 16, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion